Newsroom
  • July 16 , 2020

    Pin-prick blood test used to test for radiation exposure in mice

    A team of researchers at The Ohio State University has developed a pin-prick-type blood test for measuring the amount of radiation exposure in mice. In their paper published in the journal Science Translational Medicine, the group describes building on previous work to develop the test, and how well it worked in lab mice.
    Read more
  • July 15 , 2020

    Infusion of certain immune cells may help in severe coronavirus cases

    An infusion of cells that dampen the body's immune response might help people with severe cases of the new coronavirus recover more quickly, a new report suggests.
    Read more
  • July 15 , 2020

    Immunotherapy with CAR T cells results in exceptional patient recovery

    In a clinical trial evaluating a novel immunotherapy option for cancer treatment, a child with rhabdomyosarcoma, a form of muscle cancer, that had spread to the bone marrow, showed no detectable cancer following treatment with chimeric antigen receptor (CAR) T cells that were engineered to target the HER2 protein on the surface of the cancer cells.
    Read more
  • July 15 , 2020

    Boosting immune memory could reduce cancer recurrence

    Blocking a newly identified "immune memory checkpoint" in immune cells could improve immunotherapy and help prevent cancers from recurring, according to new findings in mice and human samples by researchers at the UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine. The research was published this week in Nature Immunology.
    Read more
  • July 15 , 2020

    Sylvester researchers identify protein target that might ease graft versus host disease

    In a new study published in Science Translational Medicine, Robert Levy, Ph.D., along with graduate student and first author Cameron Bader and colleagues, have shown that inhibiting the STING protein pathway could protect certain patients from graft versus host disease, the most serious complication from bone marrow (stem cell) transplants.
    Read more
  • July 14 , 2020

    First Coronavirus Vaccine Tested in Humans Shows Early Promise

    An experimental coronavirus vaccine made by the biotech company Moderna provoked a promising immune response against the virus and appeared safe in the first 45 people who received it, researchers reported on Tuesday in The New England Journal of Medicine.
    Read more
  • July 13 , 2020

    Amgen Announces Additional Investment In BeiGene

    Amgen (NASDAQ:AMGN) today announced an additional investment of approximately $421 million in BeiGene's registered direct offering of ordinary shares
    Read more
  • July 13 , 2020

    Cancer Stakeholders Call for Consensus of Terms to Encourage Patients’ Genetic Testing

    Read more
  • July 13 , 2020

    Massachusetts biotech Revitope scores first collaboration thanks to dual-engaging T cell platform

    Revitope Oncology began 2020 hopeful that its cancer immunology platform would be finally ready to flourish. On Monday night, that platform nabbed the biotech its first collaboration.
    Read more
  • July 13 , 2020

    Coronavirus vaccine update: Bharat Biotech starts human trials; Russia successfully completes human testing

    As global efforts are on to develop a safe and affordable COVID-19 vaccine, the big question remains unanswered: When will it be ready? India, which is only behind the United States and Brazil in coronavirus numbers, is also quickening up its pace to find a potent drug as early as possible. However, since the Centre is yet to announce a national policy on CO
    Read more
  • July 12 , 2020

    Takeda Provides Updates on Its Pharmacokinetic-guided Prophylaxis Studies at ISTH 2020, Reinforcing Its Commitment to Advancing Personalized Care for People with Bleeding Disorders

    The Data Demonstrating Benefits of Pharmacokinetic-Guided Prophylaxis Therapy in Hemophilia and von Willebrand Disease are Among 13 Presentations from Takeda’s Hematology Portfolio and Pipeline
    Read more
  • July 8 , 2020

    Contract Research Organization (CRO) Market in China 2020 Analysis to 2024 – Application, Emerging Trends and Leading Players

    China CRO market value is anticipated to reach US$27.04 billion in 2024, growing at a CAGR of 27.06%, for the period spanning from 2020 to 2024.
    Read more
If you would like to get in touch with us, please click here. Contact us